Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial.

Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial.

<h4>Introduction</h4>The novel coronavirus pandemic (COVID-19) represents a major public health problem and it is key to find a treatment that reduces mortality. Our objective was to estimate whether treatment with 400 mg/day of Hydroxychloroquine for 10 days reduces in-hospital mortalit...

Full description

Saved in:
Bibliographic Details
Main Authors: Carmen Hernandez-Cardenas, Ireri Thirion-Romero, Sebastián Rodríguez-Llamazares, Norma E Rivera-Martinez, Patricia Meza-Meneses, Arantxa Remigio-Luna, Rogelio Perez-Padilla, Research Group on hydroxychloroquine for COVID-19
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/865a4ab2b6794dd8b110faeb5370270f
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/865a4ab2b6794dd8b110faeb5370270f

Similar Items